PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 82 | 4 | 199-211
Tytuł artykułu

Hypertension Crisis in Adrenal Surgery and Treatment of Postoperative Hypotension

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
The aim of the study was to present our experience in the treatment of pheochromocytoma, which can have untypical manifestations or their complete lack. Surgery still is the main treatment. Since introducing minimally invasive method the operative choice between open and videoscopic still remains.The proper diagnosis, preparation and surgical treatment allow to avoid serious cardiovascular complications. In the treatment, pre-or intraoperative hypertensive crisis and hypotension appearing after removing the tumor are the important issues. Based on our study from 29.10.1997 to 31.01.2009 authors are showing methods and principles of preparation and the intra- and post-operative complications associated with performed operation.Additionally the problem of pheochromocytomas, clinically asymptomatic, so-called silent pheochromocytoma is discussed. Evaluated material consisted of 125 patients with pheochromocytoma. 32 (25,6%) were operated by open, classical method, and 93 (74.4%) laparoscopically via lateral transperitoneal approach.Conclusions. 1. The course and the result of surgical treatment of pheochromocytomas depend on proper diagnosis and preoperative preparation. 2. Laparoscopic adrenalectomy through lateral transperitoneal approach should be acknowledge as the referential operation in the treatment of pheochromocytoma. 3. Clinically asymptomatic pheochromocytoma require routine preparation similarly to other forms of pheochromocytoma.
Wydawca

Rocznik
Tom
82
Numer
4
Strony
199-211
Opis fizyczny
Daty
wydano
2010-04-01
online
2010-09-15
Twórcy
autor
  • Department of General, Vascular and Transplant Surgery, Warsaw Medical University
  • Department of General, Vascular and Transplant Surgery, Warsaw Medical University
  • Department of Hypertension, Institute of Cardiology, Warsaw
  • Department of Hypertension, Institute of Cardiology, Warsaw
  • II Department of Anesthesiology and Intensive Care, Warsaw Medical University
  • Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw
  • Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw
autor
  • Department of General, Vascular and Transplant Surgery, Warsaw Medical University
Bibliografia
  • Grupa Robocza Polskiego Towarzystwa Nadciśnienia Tętniczego: Wytyczne dotyczące diagnostyki i leczenia chorych z guzem chromochłonnym. Nadciśnienie Tętnicze 2006; 10: 1-19.
  • Eisenhofer G: Pheochromocytoma: recent advances and speed bumps in the road to further progress. J Hypertens 2006; 24: 2341-42.[Crossref]
  • Sardesai SH, Mourant AJ, Sivathandon Y et al.: Pheochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990; 63: 234-37.
  • Otto M: Operacyjne leczenie guzów nadnerczy. W: Januszewicz A, Szczepańska-Sadowska E, Sznajderman M (red.) Nadciśnienie Tętnicze. Medycyna Praktyczna; Kraków 2007, s. 849-859.
  • Miccolli P, Rafaelli M, Berti P et al.: Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg 2002; 89: 779-82.
  • Brouwers FM, Cenders JW, Eisenhofer G et al.: Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003; 4: 121-28.
  • Prys-Roberts C Pheochromocytoma - recent progress in its management. Br J Anaesth 2000; 85: 44-57.
  • Shen SJ: Perioperative hypertensive crisis in clinically silent pheochromocytomas: report of four cases. Chang Gung Med J 2005; 28: 44-50.
  • Reisch N, Pęczkowska M, Januszewicz A et al.: Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006; 24: 2331-39.[Crossref]
  • Werbel SS, Ober KP: Pheochromocytoma. Update on diagnosis, localization and management. Med Clin North Am 1995; 79: 131-53.
  • Goldstein RE, O'Neil JA, Holcomb GW Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999; 229: 755-766.
  • Lenders JWM, Eisenhofer G, Mannelli M et al.: Pheochromocytoma. Lancet 2005; 366: 665-75.
  • Manger WM, Eisehofer G: Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 2004; 6: 477-84.
  • Newell KA, Prinz RA, Pickleman J et al.: Pheochromocytoma multisystem crisis. A surgical emergency. Arch Surg 1988; 123: 956-59.
  • Miyajima A, Nakashima J, Baba S et al.: Incidentally discovered pheochromocytoma. J Urol 1997; 157: 1566-68.
  • Bravo EL: Pheochromocytoma: new concepts and future trends. Kidney Int 1991; 40: 544-51.[Crossref]
  • Newell KA, Prinz RA, Brooks MH et al.: Plasma catecholamine changes during excision of pheochromocytoma. Surgery 1988; 104: 1064-71.
  • Boutros AR, Bravo E, Zanettin G et al.: Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med 1990; 57: 613-19.
  • Gross MD, Shapiro B: Clinical review 50: clinically silent adrenal masses. J Clin Endocr Metab 1993; 77: 885-94.
  • Krane NK: Clinically unsuspected pheochromocytoma. Arch Intern Med 1986; 146: 54-62.
  • Lucon Am, Pereira MA, Mendonca BB et al.: Pheochromocytoma: study of 50 cases. J Urol 1997; 157: 1208-12.
  • Neumann HPH, Berger DP, Sigmund G et al.: Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med 1993; 329: 1531-38.
  • Pacak K, Ilias I, Adams KT et al.: Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Int Med 2005; 257: 60-68.
  • Ulchaker JC, Goldfarb DA, Bravo EL et al.: Successful outcomes in pheochromocytoma surgery in the modern era. J Urol 1999; 161: 764-67.
  • Mackenzie IS, Brown MJ: Pseudopheochromocytoma. J Hypertens 2007; 25: 2204-06.[Crossref][PubMed]
  • Sharabi Y, Goldstein DS, Bentho O et al.: Sympathoadrenal function in patients with paroxysmal hypertension - pseudopheochromocytoma. J Hypertens 2007; 25: 2286-95.[Crossref][WoS]
  • Amos AM, McRoberts JW: Cushing's syndrome associated with a pheochromocytoma. Urology 1998; 52: 331-35.[Crossref]
  • Tan GH, Carney JA, Grant CS et al.: Coexistence of bilateral adrenal pheochromocytoma and idiopathic hyperaldosteronism. Clin Endocrinol 1996; 44: 606-09.
  • Kaltsas GA, Papadogias D, Grossman AB: The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumors (pheochromocytomas and paraganglioma). W: Lehnert H. (red.) Pheochromocytoma, pathophysiology and clinical management. Front Horm Res Basel, Karger 2004; s.61-75.
  • Diner EK, Franks ME, Behari A et al.: Partial adrenalectomy: The National Cancer Institute experience. Urology 2005; 66: 19-23.
  • Walther MM, Herring J, Choyke P et al.: Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urolog 2000; 164: 14-17.
  • Walz MK: Extent of adrenalectomy for adrenal neoplasm: sparing (subtotal) versus total adrenalectomy. Surg Clin N Am 2004; 84: 743-53.
  • Sturgeon C, Kebebew E: Laparoscopic adrenalectomy for malignancy. Surg Clin N Am 2004; 84: 755-74.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_v10035-010-0028-7
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.